Casi Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 22.87B and sold 1.25M CASIF shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
100.00 |
| ● Buy | 22.87B shares |
| ● Sell | 1.25M shares |
|
97% Buy Activity
Moderate Negative Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jun 18, 2028 Buy |
Qian Kun Global Controller |
3 000 Value: $8K |
||
|
Jun 18, 2028 Buy |
Huang Hai Global Chief Commercial Ofcr |
7 500 Value: $20.0K |
||
|
Jun 18, 2028 Buy |
Wang Chunhua Chief Operating Officer |
7 500 Value: $20.0K |
||
|
Jun 18, 2027 Buy |
Gao Wei R General Counsel |
5 000 Value: $13.4K |
||
|
May 21, 2026 Buy |
He Wei-wu |
0 Value: $0 |
||
|
May 12, 2026 Buy |
Qian Kun Global Controller |
6 667 Value: $12.9K |
||
|
May 12, 2026 Buy |
Wang Chunhua Chief Operating Officer |
8 333 Value: $16.1K |
||
|
Mar 18, 2026 Buy |
Folinsbee Thomas Director |
11 231 Value: $30.0K |
||
|
Mar 18, 2026 Buy |
Folinsbee Thomas Director |
20 000 Value: $71.8K |
||
|
Mar 18, 2026 Buy |
Folinsbee Thomas Director |
11 231 Value: $21.7K |
||
|
Mar 18, 2026 Buy |
Folinsbee Thomas Director |
11 231 Value: $14.2K |
||
|
Mar 18, 2026 Buy |
Zeng Xuebo Director |
11 231 Value: $30.0K |
||
|
Mar 18, 2026 Buy |
Zeng Xuebo Director |
11 231 Value: $21.7K |
||
|
Mar 18, 2026 Buy |
Zeng Xuebo Director |
11 231 Value: $14.2K |
||
|
Mar 18, 2026 Buy |
Gao Wei R General Counsel |
10 000 Value: $57.8K |
||
|
Mar 18, 2026 Buy |
Gao Wei R General Counsel |
4 000 Value: $8K |
||
|
Mar 18, 2026 Buy |
Qian Kun Global Controller |
5 000 Value: $28.9K |
||
|
Mar 18, 2026 Buy |
Huang Hai Global Chief Commercial Ofcr |
100 000 Value: $661.0K |
||
|
Mar 18, 2026 Buy |
Wang Chunhua Chief Operating Officer |
20 000 Value: $115.6K |
||
|
Mar 18, 2026 Buy |
Zukiwski Alexander A Global Chief Medical Officer |
13 333 Value: $25.7K |
||
|
Mar 18, 2026 Buy |
Krebs-pohl Barbara Helene Hannelore Director |
10 000 Value: $64.1K |
||
|
Mar 18, 2026 Buy |
Krebs-pohl Barbara Helene Hannelore Director |
10 000 Value: $23.1K |
||
|
Mar 18, 2026 Buy |
Wu Alex Director |
0 Value: $0 |
||
|
Mar 18, 2026 Buy |
Wu Alex Director |
11 753 Value: $14.8K |
||
|
Mar 18, 2026 Buy |
Wu Alex Director |
11 753 Value: $31.4K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
Sign In
Buy CASIF